SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-336571
Filing Date
2018-11-28
Accepted
2018-11-28 16:08:33
Documents
40
Period of Report
2018-11-28

Document Format Files

Seq Description Document Type Size
1 6-K d602356d6k.htm 6-K 13539
2 EX-99.1 d602356dex991.htm EX-99.1 181604
3 EX-99.2 d602356dex992.htm EX-99.2 96905
4 EX-99.3 d602356dex993.htm EX-99.3 75935
11 GRAPHIC g602356g76b68.jpg GRAPHIC 8098
  Complete submission text file 0001193125-18-336571.txt   1599693

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT asnd-20180930.xml EX-101.INS 214260
6 XBRL TAXONOMY EXTENSION SCHEMA asnd-20180930.xsd EX-101.SCH 22303
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20180930_cal.xml EX-101.CAL 34781
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20180930_def.xml EX-101.DEF 62363
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20180930_lab.xml EX-101.LAB 170335
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20180930_pre.xml EX-101.PRE 123273
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 181205720
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1